Tislelizumab
BeiGene
[]
rationale 305 (phiii): tislelizumab (anti-pd1 moab) improves os when added to ct as 1l therapy in pts w/ pd-l1 + her-2neg mgc/gej adc #gi23 
Gastrointestinal Medical Oncologist. Professor of Medicine and Attending Physician at University of Nuevo Leon Cancer Center.  🇲🇽